The Pharmaceutical Market: Turkey

Date: January 31, 2013
Pages: 98
Price:
US$ 1,295.00
License [?]:
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PD4902A4F6BEN
Leaflet:

Download PDF Leaflet

The Pharmaceutical Market: Turkey
OVERVIEW OF THE PHARMACEUTICAL MARKET IN TURKEY

The cooling economic environment and the weakening lira has moderated optimistic forecasts on the Turkish pharmaceutical market, especially as the government is the single largest reimburser of pharmaceuticals, covering 80-85% of total drug expenditure through various insurance and immunisation schemes. Price cutting and public discount decrees announced in November 2011 continue to affect the pharmaceutical market in 2012, as highlighted by the decrease in pharmaceutical spending in the first half of this year.

Headline Expenditure Projections

Pharmaceuticals: TRY17.21bn (US$10.24bn) in 2011 to TRY16.35bn (US$9.03bn) in 2012; -5.0% in local currency terms and -11.8% in US dollar terms. Local currency forecast downgraded from Q 4 12 on account of H112 data .

Healthcare: TRY83.59bn (US$49.75bn) in 2011 to TRY92.02bn (US$50.84bn) in 2012; +10.1% in local currency terms and +2.2%in US dollar terms. Local currency forecast slightly increased from Q 4 12 due to increased healthcare investment .

Medical devices: TRY4.33bn (US$2.58bn) in 2011 to TRY4.78bn (US$2.64bn) in 2012; +10.3% in local currency terms and +2.4% in US dollar terms. Local currency forecast broadly unchanged from Q 4 12.

Competitive Landscape

The Competitive Landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
EXECUTIVE SUMMARY

SWOT ANALYSIS

    Turkey Pharmaceuticals And Healthcare Industry SWOT
    Turkey Political SWOT
    Turkey Economic SWOT
    Turkey Political SWOT

PHARMACEUTICALS & HEALTHCARE RISK/REWARD RATINGS

    Table: Central And Eastern Europe Pharmaceuticals & Healthcare Risk/Reward Ratings (RRRs), Q113
    Rewards
    Risks

TURKEY – MARKET SUMMARY

REGULATORY REGIME

    Intellectual Property Regime
    Market Access Issues
    Pricing Regime
    Table: Turkish Pharmaceutical Pricing Decrees
    Drug Price Inflation
    Reimbursement Regime
    Table: Pharmacist discount related to annual sales revenue (VAT excluded)

INDUSTRY DEVELOPMENTS

    Epidemiology
    Non-Communicable Diseases
    Healthcare Sector
    Healthcare Insurance
    Healthcare Infrastructure
    Healthcare Financing
    Research & Development
    Clinical Trials Industry
    Medical Devices Industry

INDUSTRY FORECAST SCENARIO

    Overall Market Forecast
    Table: Turkey Pharmaceutical Sales, Historical Data And Forecasts
    Healthcare Market Forecast
    Table: Turkey Healthcare Expenditure Trends, Historical Data And Forecasts
    Table: Turkey Government Healthcare Expenditure Trends, Historical Data And Forecasts
    Table: Turkey Private Healthcare Expenditure Trends, Historical Data and Forecasts
    Key Growth Factors – Macroeconomic
    Table: Turkey - Economic Activity
    Prescription Drug Market Forecast
    Table: Turkey Prescription Drug Market Indicators, Historical Data And Forecasts
    Patented Drug Market Forecast
    Generic Drug Market Forecast
    Table: Turkey Generics Drug Market Indicators, Historical Data And Forecasts
      OTC Medicine Market Forecast
      Table: Turkey Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts
      Pharmaceutical Trade Forecast
      Table: Turkey Pharmaceutical Trade Data And Forecasts (US$mn)
      Table: Turkey Pharmaceutical Trade Data And Forecasts (TRYmn)
      Medical Device Market Forecast
      Table: Turkey Medical Device Market Indicators, Historical Data And Forecasts
      Other Healthcare Data
      Key Risks To BMI’s Forecasts

COMPETITIVE LANDSCAPE

      Pharmaceutical Sector
      Domestic Industry
      Foreign Industry
      Company Activity
  Wholesale
  Retail

COMPANY PROFILES

  Local Companies
      Abdi İbrahim
      Eczacibaşi Pharmaceuticals
      Sanovel Pharmaceuticals
      Deva (EastPharma)
      Mustafa Nevzat Ilac Sanayi (MN) Pharmaceuticals
  Multinational Companies
      Novartis
      Pfizer
      Sanofi
      GlaxoSmithKline
      Roche
      AstraZeneca
      Bayer
      Merck & Co

DEMOGRAPHIC OUTLOOK

      TURKEY - Population By Age Group
      TURKEY - Population By Age Group
      TURKEY - Key Population Ratios
      TURKEY - Rural and Urban Population

GLOSSARY

BMI METHODOLOGY

      How We Generate Our Pharmaceutical Industry Forecasts
      Risk/Reward Ratings Methodology
      Ratings Overview
      Table: Pharmaceutical Business Environment Indicators
      Weighting
      Table: Weighting Of Components
      Sources
Skip to top


The Pharmaceutical Market: Germany US$ 1,295.00 Jan, 2013 · 112 pages
The Pharmaceutical Market: Hungary US$ 1,295.00 Jan, 2013 · 95 pages
The Pharmaceutical Market: India US$ 1,295.00 Jan, 2013 · 117 pages

Ask Your Question

The Pharmaceutical Market: Turkey
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: